Grant ID | RP120326 |
Awarded On | November 02, 2011 |
Title | In-Situ PET Imaging for Adaptive Proton Therapy |
Program | Academic Research |
Award Mechanism | Individual Investigator |
Institution/Organization | The University of Texas M.D. Anderson Cancer Center |
Principal Investigator/Program Director | Yiping Shao |
Cancer Sites | All Sites |
Contracted Amount | $1,271,284 |
Lay Summary |
Proton therapy (PT) is a latest state-of-art radiation therapy that can focus high level radiations to a small target. In principle, this unique physical property will allow PT to become a targeted therapy for significantly improved therapy efficacy while simultaneously reduced dose to normal tissues and thus reduced treatment complications. However, PT could be more harmful than useful to a patient if the high dose were not delivered accurately. Currently, there is no noninvasive technology to monitor the distribution of radiation delivered inside a patient. This has forced clinicians take overly conservative treatment approaches in restricting doses to the tumor in order to ensure sparing ... |